NCT01058447View on ClinicalTrials.gov

Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Healthy
Interventions
DRUG

AZD1981

Oral tablet, 250 mg, single dose

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY